Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AB Cube is a France-based life sciences software company focused on pharmacovigilance and broader multivigilance workflows. Founded in 2006, the company provides the cloud-based SafetyEasy Suite, a modular platform used for adverse event intake, case management, regulatory reporting, analytics, and signal detection across pharmacovigilance, medical device vigilance, cosmetovigilance, and nutrivigilance. Its customers include biotechs, CROs, pharmaceutical companies, health authorities, and academic organizations. AB Cube operates as a commercial-stage software vendor rather than a therapeutic drug developer, and in 2026 it became part of the newly created AB Cube Group alongside Marvin and asthenis to offer a broader connected life science data ecosystem across clinical, oncology, and safety workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AB Cube.